Xiangyu Medical (688626.SH) spent 60.09 million yuan to complete the repurchase of 1.25% of the shares.
Shanghai Shuangyu Medical Technology Co., Ltd. (688626.SH) announced that on February 7, 2025, the company completed the share repurchase.
Xiangyu Medical (688626.SH) announced that on February 7, 2025, the company completed the share buyback, repurchasing a total of 2 million shares, accounting for 1.25% of the total share capital of the company. The highest repurchase price was 32.25 yuan per share, the lowest repurchase price was 28.02 yuan per share, and the average repurchase price was 30.05 yuan per share. The total amount of funds used was 60.09 million yuan (excluding transaction commissions, transfer fees, and other transaction costs).
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


